MARK CORRIGAN Insider Trading $NVLN NOVELION THERAPEUTICS INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK CORRIGAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK CORRIGAN. MARK CORRIGAN is Executive VP, R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive, VP R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Director in NOVELION THERAPEUTICS INC. ($QLTI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and Director in Wave Life Sciences Ltd. ($WVE) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV).

MARK CORRIGAN in NOVELION THERAPEUTICS INC.

Trading Symbol: NVLN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK CORRIGAN: Director
Holdings: 0 shares
Latest Transaction: Aug 13 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of MARK CORRIGAN in NOVELION THERAPEUTICS INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CLCD, CRXX, NBRV, NBRV, NVLN, SEPR, WVE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 13 2018NVLNNOVELION THERAPEUT ...CORRIGAN MARKDirectorOption ExerciseA3.3350,000166,50050,000
Mar 31 2017QLTINOVELION THERAPEUT ...CORRIGAN MARKDirectorOption ExerciseA10.649,600102,1449,600

Page:   1